Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fatima Laraba-Djebari has a total of 217 co-authors. Here are the top co-authors by number of shared publications:

  • Sonia Adi-Bessalem

    University of Science and Technology Houari Boumediène, Algeria

    23 shared publications
  • Djelila Hammoudi-Triki

    Laboratory of Cellular and Molecular Biology, Faculty of Biological Sciences, USTHB, BP 32, El Alia, Bab Ezzouar, 16111, Algiers, Algeria

    11 shared publications
  • Marie-France Martin-Eauclaire

    Aix Marseille Université, CRN2M UMR 7286, CNRS, 13344 Marseille Cedex 15, France

    10 shared publications
  • Fatah Chérifi

    Faculty of Biological Sciences, Laboratory of Cellular and Molecular Biology, University of Science and Technology Houari Boumediene (USTHB), BP 32 El-Alia, Bab Ezzouar, Algiers, Algeria

    7 shared publications
  • Habiba Oussedik-Oumehdi

    USTHB, Faculty of Biological Sciences, Laboratory of Cellular & Molecular Biology, BP 32, El-Alia, Bab Ezzouar, 16111, Algiers, Algeria

    7 shared publications
  • Aouatef Ait-Lounis

    USTHB, Faculty of Biological Sciences, Laboratory of Cellular and Molecular Biology, BP 32 El-Alia, Bab Ezzouar, Algiers, Algeria

    6 shared publications

Latest Publications

  • Thymol Attenuates Klebsiella pneumoniae Induced Lung Injury via Modulation of Peroxidase‐Driven Oxidative Stress and Host–Pathogen Interactions: In Vivo and In Silico Insights

    by Meriem Amarni, Amina Ladjel‐Mendil, Fawzi Allala, Fatah Cherifi, Amel Bouanane‐Darenfed, Hadjila Moussaoui, Rania Merzouagui, Nesrine Ahras‐Sifi, Fatima Laraba‐Djebari

    Klebsiella pneumoniae pneumonia drives excessive inflammatory and oxidative responses that culminate in acute lung injury (ALI) and impaired bacterial clearance. Effective therapies capable of restoring host–pathogen balance remain limited, particularly in the context of multidrug‐resistant strains. This study investigated the therapeutic efficacy of thymol in a murine model of K. pneumoniae ‐induced ALI. Oral thymol (5–20 mg/kg) markedly reduced lung injury, suppressed leukocyte infiltration, improved pulmonary histoarchitecture, and significantly enhanced bacterial clearance. Thymol reshaped systemic and local immune responses by decreasing tumor necrosis factor‐α (TNF‐α) and C‐reactive protein (CRP), increasing interleukin‐10 (IL‐10), and limiting macrophage and granulocyte recruitment. Mechanistically, thymol attenuated heme peroxidase‐driven oxidative stress, as evidenced by reduced myeloperoxidase (MPO) and eosinophil peroxidase (EPO) activities, decreased malondialdehyde (MDA), hydrogen peroxide (H 2 O 2 ), and nitric oxide (NO), along with restoration of catalase activity and glutathione levels. Complementary in silico docking predicted stable interactions of thymol with MPO and EPO, as well as essential bacterial metabolic enzymes, including deoxy‐D‐xylulose‐5‐phosphate synthase (DXS), acetolactate synthase (ALS), and dihydrodipicolinate synthase (DHDPS). Collectively, these findings suggest that thymol may act as a multi‐target bioactive compound capable of modulating host inflammatory and redox pathways while potentially impairing bacterial metabolic fitness, thereby mitigating pneumonia‐associated ALI.

  • AaTs-1, a Tetrapeptide from Scorpion Venom Mitigates Demyelination and Neuroinflammation in a Cuprizone-Induced Model of Multiple Sclerosis

    by Hadjila Moussaoui, Meriem Amarni, Amina Ladjel-Mendil, Mohamed-Chiheb Saada, Wassim Moslah, Merzouagui Rania, Najet Srairi-Abid, Fatima Laraba-Djebari

  • Redox-driven antiplatelet effect of snake venom phospholipase A2: VLPLA2 from Vipera lebetina venom as a new antithrombotic agent

    by Amel Kadi-Saci, Fatima Laraba-Djebari

    Background: Snake venom phospholipases A2 are multifunctional enzymes which modulate haemostatic balance. Their antithrombotic potential via redox-sensitive signalling pathways remains underexplored. Objectives: This study reports the redox-mediated antiplatelet effects of vipera l ebetina phospholipase A2 (VLPLA2), a phospholipase A2 purified from Vipera lebetina , we also assess its potential as a novel antithrombotic agent. Methodology: VLPLA2 was evaluated for its effects on human platelet aggregation, redox signalling pathways and antioxidant enzyme modulation. The involvement of VLPLA2 in platelet adhesion to fibrinogen was also investigated. Results: VLPLA2 strongly inhibited ADP-induced platelet aggregation and platelet adhesion to fibrinogen, probably by increasing catalase activity and reducing hydrogen peroxide levels, suggesting a compensatory redox response. The antiplatelet effect of VLPLA2 appears to be mediated by ROS overproduction, possibly via the involvement of nicotinamide adenine dinucleotide reduced phosphate (NADPH) oxidase signalling pathways. This redox imbalance leads to oxidative modifications of P2Y12 ADP receptor and GPIIb/IIIa fibrinogen receptor, consequently, avoiding their activation. Conclusions: Our data reveal a dual mechanism of VLPLA2 via enzymatic membrane phospholipid hydrolysis and oxidative modulation of platelet signalling pathways. VLPLA2 could be a promising candidate for the development of redox-targeted antithrombotic therapeutics.

  • Enhanced production and immuno-toxicological evaluation of chicken egg yolk antibodies (IgY) in laying hens immunized with scorpion venom

    by Ahlem Seghouani-Baitiche, Amal Megdad-Lamraoui, Sonia Adi-Bessalem, Fares Daachi, Ghania Zitouni, Fatima Laraba-Djebari

  • Open Access

    Proteasome-driven modulation of immune and oxidative pathways during scorpion envenomation pathogenesis

    by Amal Megdad-Lamraoui, Sonia Adi-Bessalem, Fares Daachi, Fatima Laraba-Djebari

    Background: Scorpion venom contains a variety of toxin molecules that are the drivers of inflammation and oxidative stress, leading to significant tissue damage. While several mechanisms underlying these responses have been studied, the involvement of the proteasome complex - a key regulator of inflammation - remains poorly understood. This study explored the role of the proteasome in modulating inflammatory and oxidative responses to envenomation by Androctonus australis hector venom. Methods: Mice were pretreated intraperitoneally with bortezomib, a proteasome inhibitor, at low (0.05 mg/kg), medium (0.25 mg/kg), or high (0.5 mg/kg) doses, 30 minutes prior to sublethal venom administration (0.5 mg/kg, subcutaneous). Twenty-four hours after venom administration, animals were euthanized, blood and organs were collected to evaluate vascular permeability (via Evans blue dye extravasation), the extent of inflammatory cell infiltration (myeloperoxidase and eosinophil peroxidase enzymatic activities), and oxidative/nitrosative stress markers (nitric oxide, hydrogen peroxide, malondialdehyde, catalase activity, and glutathione). Histopathological examinations were performed to identify structural alterations, such as edema, hemorrhage, and cellular infiltration. Biochemical parameters reflecting organ function, including serum levels of CPK, LDH, ALT, ALP, urea, and creatinine, were also measured to assess the degree of systemic damage. Results: Our findings revealed a dose-dependent immune-modulatory role of the proteasome system. A medium dose of bortezomib reduced inflammatory and oxidative stress markers, such as vascular permeability, eosinophil peroxidase, neutrophil peroxidase, nitric oxide, and malondialdehyde in renal tissue, suggesting a reduction in local inflammation and oxidative damage. In contrast, a higher dose showed pronounced preventive effects in cardiopulmonary and hepatic tissues, significantly reducing inflammatory mediators and oxidative markers, restoring antioxidant enzyme activity (catalase) and glutathione, as well as, improving tissue structure and organ function. Conclusion: These findings underscore the proteasome involvement in inflammatory regulation, likely through modulation of vascular permeability, immune cell activation, and oxidative stress, making it a key target in scorpion envenomation.


  • Open Access

    Influence of envenomation timing on peripheral immune and oxidative responses in experimental scorpion envenomation

    by Fares Daachi, Sonia Adi-Bessalem, Amal Megdad-Lamraoui, Fatima Laraba-Djebari

    Background: Scorpion envenomation poses a significant health threat in endemic regions, eliciting complex immune responses in affected individuals. Recent research suggests that the timing of envenomation - whether it occurs during the day or night - may influence the host inflammatory response and subsequent organ damage. This study investigates the impact of envenomation timing on host inflammatory and oxidative responses using an experimental scorpion envenomation model. Methods: Mice were divided into two groups, corresponding to their resting phase (day) and activity phase (night), and were monitored for twenty-four hours post-envenomation. We analyzed systemic inflammatory markers, hormonal changes within the hypothalamic-pituitary-adrenal (HPA) axis, and assessed liver toxicity. Results: Our findings reveal that the release of the myeloperoxidase enzyme, along with the pro-inflammatory cytokines IL-6 and IL-17, varied significantly based on the timing of envenomation. Notably, envenomation occurring during the nighttime resulted in elevated levels of these mediators. We also observed a pronounced imbalance in oxidative stress, characterized by a higher presence of prooxidant species during the daytime and enhanced antioxidant activities during the nighttime. This diurnal variation highlights the dynamic nature of the inflammatory and oxidative processes. Importantly, our analysis points to the probable involvement of corticosterone, the final effector of the HPA axis, in modulating these variations in the inflammatory response. By influencing both the intensity of the immune response and the degree of oxidative stress, corticosterone appears to play a pivotal role in the overall pathophysiology of scorpion envenomation. Conclusion: This study provides valuable insights into how the timing of scorpion envenomation influences inflammatory responses and organ-specific toxicity, offering potential implications for the treatment and management of envenomation cases.


  • Therapeutic Outcome of Quercetin Nanoparticles on Cerastes Cerastes Venom-Induced Hepatorenal Toxicity: A Preclinical Study

    by Kahina Kiouas, Habiba Oussedik-Oumehdi, Fatima Laraba-Djebari

    Aim: The objective of this study was to investigate the therapeutic potential of quercetin (QT) and QT-loaded poly(lactic-co-glycolic acid) nanoparticles (QT-NPs) on Cerastes cerastes venom-mediate... Graphical abstract


  • Therapeutic Outcome of Anti-inflammatory and Antioxidative Medicines on the Dermonecrotic Activity of Cerastes cerastes Venom

    by Abderrezak Khelfi, Habiba Oussedik-Oumehdi, Fatima Laraba-Djebari

    — Envenomation by Cerastes cerastes often results in local dermonecrotic lesions. While immunotherapy is effective in reversing systemic symptoms, this strategy remains deficient in counteracting the extended dermonecrosis induced from the bite site. In this study, the therapeutic effect of pharmacological drugs on the dermonecrotic activity of the venom was investigated. Venom administration caused a marked dermonecrotic lesion with increased levels of oxidative stress biomarkers (MPO, EPO, NO, H2O2, MDA, protein carbonyl, and thiol levels). Antioxidant capacity was decreased, as evidenced by reduced catalase, glutathione, and selenium levels. Histopathological analysis of skin biopsies revealed necrotic lesions accompanied by hemorrhage and epidermis thickening. The efficiency of cyproheptadine (C), dexamethasone (D), and tetracycline (T), as a monotherapy or in association, were evaluated on the dermonecrotic activity of the venom. Most of the treatments (CD, CT, DT, and CDT) largely reduced tissue necrosis to, respectively, 84.29, 87.83, 83.77, and 82.71% and significantly decreased MPO and EPO activities and NO, H2O2, MDA, and protein carbonyl levels in skin tissue homogenates. CT and CDT associations significantly increased the antioxidant status as indicated by enhanced catalase, glutathione, and selenium levels. The second challenge of the pharmacological associations was more effective in improving the oxidative/antioxidative balance. Skin tissue sections from treated animals with CT or CDT revealed tissue structure close to that observed in control animals. Therefore, the synergistic action of all tested drugs on the major pathways of inflammation (phospholipases A2, metalloproteinases, and histamine) seems to be efficient to neutralize the necrotic activity of the venom.


  • Neuromodulation of neurological disorders in a demyelination model: effect of a potassium channel inhibitor from Androctonus scorpion venom

    by Hadjila Moussaoui, Amina Ladjel-Mendil, Fatima Laraba-Djebari

    Scorpion’s toxins have attracted attention as a treatment for diverse neurological diseases related to myelin loss. This study aimed to investigate the effect of kaliotoxin2 (KTX2), a potassium-channel blocker from Androctonus australis hector venom on cuprizone model of demyelination. Results showed that KTX2 modulates the behavioral functions, the demyelination, and reduces the recruitment of microglia, astrocytes, and granulocyte in the brain. KTX2 modulates the inflammatory response by increasing the IL-10 release, attenuating NFκB activation, and decreasing the oxidative stress markers and IL-6 levels. Results highlight the modulating effects of KTX2 on cuprizone model and confirm its therapeutic potential in demyelination diseases.